Search Results - "Wissniowski, Thaddeus T"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer by Di Fazio, Pietro, Waldegger, Petra, Jabari, Samir, Lingelbach, Susanne, Montalbano, Roberta, Ocker, Matthias, Slater, Emily P, Bartsch, Detlef K, Illig, Romana, Neureiter, Daniel, Wissniowski, Thaddeus T

    Published in Oncotarget (17-05-2016)
    “…Autophagy is a homeostatic, catabolic degradation process and cell fate essential regulatory mechanism. Protracted autophagy triggers cell death; its aberrant…”
    Get full text
    Journal Article
  2. 2

    Fibromyalgia syndrome: metabolic and autophagic processes in intermittent cold stress mice by Oezel, Lisa, Then, Hanna, Jung, Anna L., Jabari, Samir, Bonaterra, Gabriel A., Wissniowski, Thaddeus T., Önel, Susanne F., Ocker, Matthias, Thieme, Kati, Kinscherf, Ralf, Di Fazio, Pietro

    Published in Pharmacology research & perspectives (01-10-2016)
    “…Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue, and depression. The aim was to analyze potential mitochondrial dysfunction or…”
    Get full text
    Journal Article
  3. 3
  4. 4

    MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5 by Damanakis, Alexander I., Eckhardt, Sabine, Wunderlich, Annette, Roth, Silvia, Wissniowski, Thaddeus T., Bartsch, Detlef K., Di Fazio, Pietro

    “…Purpose Thyroid cancer (TC), the most common endocrine malignancy, increases its incidence worldwide. MicroRNAs have been shown to be abnormally expressed in…”
    Get full text
    Journal Article
  5. 5

    Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma by Wirries, André, Jabari, Samir, Jansen, Esther P, Roth, Silvia, Figueroa-Juárez, Elizabeth, Wissniowski, Thaddeus T, Neureiter, Daniel, Klieser, Eckhard, Lechler, Philipp, Ruchholtz, Steffen, Bartsch, Detlef K, Boese, Christoph K, Di Fazio, Pietro

    Published in Oncotarget (31-08-2018)
    “…Osteosarcoma is an aggressive cancer with a poor long term prognosis. Neo-adjuvant poly-chemotherapy followed by surgical resection remains the standard…”
    Get full text
    Journal Article